{
    "id": 2795,
    "fullName": "ID1 over exp",
    "impact": "none",
    "proteinEffect": "no effect",
    "geneVariantDescriptions": [
        {
            "description": "ID1 over exp indicates an over expression of the Id1 protein. However, the mechanism causing the over expression is unspecified.",
            "references": [
                {
                    "id": 275,
                    "pubMedId": null,
                    "title": "External Reference Not Available (N/A)",
                    "url": "https://ckb.jax.org/about/glossaryOfTerms"
                }
            ]
        }
    ],
    "type": "non-specific",
    "gene": {
        "id": 3397,
        "geneSymbol": "ID1",
        "terms": [
            "ID1",
            "bHLHb24",
            "ID"
        ]
    },
    "variant": "over exp",
    "createDate": "12/19/2014",
    "updateDate": "07/31/2019",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2155,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, cannabidiol was demonstrated to inhibit ID1 gene transcription and subsequent cell migration and invasion in cultured glioblastoma cells over expressing Id1 (PMID: 23243024).",
            "molecularProfile": {
                "id": 2610,
                "profileName": "ID1 over exp"
            },
            "therapy": {
                "id": 2632,
                "therapyName": "Cannabidiol",
                "synonyms": null
            },
            "indication": {
                "id": 3068,
                "name": "glioblastoma multiforme",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 2665,
                    "pubMedId": 23243024,
                    "title": "Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23243024"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 1496,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, the combination of Taxol (paclitaxel) and (Platinol) cisplatin decreased Id1 protein expression and cell viability in Id1-overexpressing human non-small cell lung cancer cell lines in culture and reduced tumor growth in xenograft models (PMID: 25344919).",
            "molecularProfile": {
                "id": 2610,
                "profileName": "ID1 over exp"
            },
            "therapy": {
                "id": 1812,
                "therapyName": "Cisplatin + Paclitaxel",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1415,
                    "pubMedId": 25344919,
                    "title": "High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25344919"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 1495,
            "approvalStatus": "Clinical Study - Cohort",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a clinical study, non-small cell lung cancer patients with increased Id1 expression demonstrated increased survival following treatment with Taxol (paclitaxel) and Platinol (cisplatin) compared to patients with low Id1 expression (PMID: 25344919).",
            "molecularProfile": {
                "id": 2610,
                "profileName": "ID1 over exp"
            },
            "therapy": {
                "id": 1812,
                "therapyName": "Cisplatin + Paclitaxel",
                "synonyms": null
            },
            "indication": {
                "id": 3908,
                "name": "lung non-small cell carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 1415,
                    "pubMedId": 25344919,
                    "title": "High Id1 expression, a generally negative prognostic factor, paradoxically predicts a favorable prognosis for adjuvant paclitaxel plus cisplatin therapy in surgically treated lung cancer patients.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/25344919"
                }
            ],
            "ampCapAscoEvidenceLevel": "C",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 2610,
            "profileName": "ID1 over exp",
            "profileTreatmentApproaches": [
                {
                    "id": 4508,
                    "name": "USP1 inhibitor",
                    "profileName": "ID1 over exp"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}